7investing's November recommendations are now live! Come take a look at the 7 stocks our advisors have chosen as their favorite opportunities in the market this month.
November 1, 2022
Welcome to 7investing in November!
Our 7investing service provides 7 stock recommendation reports each month and we just published our newest picks earlier this morning. We’d love you to see all of them — including all of our previous picks too — by setting up a new 7investing membership today! (Pro tip: Click right here to immediately get started for just $1 and to save 25% for life on our annual option.)
Our advisor team ran across the entire investing spectrum this month, from a very-high-risk biotechnology company to a low-risk industrial juggernaut:
This section has two different formats. 7investing site visitors who are not logged-in will see a broader description of the picks. Logged in subscribers will see more detailed descriptions of each of the recommendations.
7investing advisor Dana Abramovitz is putting her PhD in biochemistry to good use this month, picking a small cap Biotechnology recommendation. She believes the company is becoming a leader in drug delivery — ensuring the right drug gets to the right place at the right time.
Matt Cochrane went with a low-risk Industrial pick, which he brilliantly describes as “a hedge against bad things happening in the world.” Several other advisors applauded Matt’s pick this month during the team’s Deep Dive video call, as many are also long-time shareholders of the company.
7investing CEO Simon Erickson began a voyage in unchartered waters, recommending a mid cap Semiconductors company that is a new name to most investors. Simon believes the company will provide one of the most important building blocks for the fast-growing electric vehicle market.
Luke Hallard went international this month, picking a telecom company who is connecting one of the world’s fastest-growing continents. In addition to his rec, Luke recently did a fantastic job at describing how investors can use ADRs to purchase foreign-based companies into their portfolios.
Anirban Mahanti, Krzysztof Piekarski, and Steve Symington all went with Enterprise Software recommendations this month, with various market capitalizations and risk levels. Several bigger-picture trends are taking shape in the software world, and these recommendations are at the very forefront of three of them.
Investing is the stock market is a lifelong journey that involves much more than just reading a single month’s reports. If you’re a long-term investor, we believe you likely want to see ongoing coverage of your companies and an ability to ask questions about them over time.
We’ve built 7investing to enable that, helping to guide you through the long-term journey and to learn which types of stocks are right for you. We purposely make recommendations of all types — from moderate risk to very high risk; from Industrial to Biotechnology — so you can find the right fit for your portfolio. Our recommendation reports each take 5-10 minutes to read, and we offer an opportunity for you to discuss them with us in our Subscriber Calls and Community Forum.
If you would like to sign up with 7investing and see all recommendations since our launch in March 2020, please click here to get started with 7investing today!
Questions about our 7investing membership? Email us at firstname.lastname@example.org
Already a 7investing member? Log in here.